Strobeck Mark
President and CEO
Strobeck Mark has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Oct 5, 2026.
On the most recent filing, Strobeck Mark is listed as President and CEO at ROCKWELL MEDICAL, INC. Inside the rolling window, Strobeck Mark reported no open-market purchases and 1 open-market sale totaling $8K in RMTI.
Companies traded
Other insiders at RMTI
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$8K
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Oct 1, 2025 | RMTI | Sale | $8K |
Frequently asked questions
How many SEC Form 4 filings has Strobeck Mark made?
Strobeck Mark has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company since 2025.
Which companies does Strobeck Mark trade?
Strobeck Mark has filed SEC Form 4 disclosures for 1 company, including RMTI.
When was Strobeck Mark's most recent SEC Form 4 filing?
Strobeck Mark's most recent SEC Form 4 filing on Tracefour is dated Oct 5, 2026.
What is Strobeck Mark's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Strobeck Mark is listed as President and CEO.
What is Strobeck Mark's total buy and sell value in the current window?
Inside the rolling retention window, Strobeck Mark bought $0 and sold $8K based on SEC Form 4 filings.
What was Strobeck Mark's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,000 RMTI shares on 2026-10-01, worth $8K, per SEC Form 4 filings.